Showing 2071-2080 of 5909 results for "".
- Foundation Fighting Blindness Appoints Peter Ginsberg as Executive Vice President, Corporate Development, Chief Business Officerhttps://modernod.com/news/foundation-fighting-blindness-appoints-peter-ginsberg-as-executive-vice-president-corporate-development-chief-business-officer/2478647/The Foundation Fighting Blindness announced the appointment of Peter Ginsberg as executive vice president, corporate development, chief business officer. Mr. Ginsberg will oversee the development of financial plans and processes while providing leadership on busines
- President-Elect Biden Picks California Attorney General to Lead HHShttps://modernod.com/news/president-elect-biden-picks-california-attorney-general-to-lead-hhs/2478630/President-elect Joe Biden plans to nominate California Attorney General Xavier Becerra to lead the Department of Health and Human Services (HHS), according to
- Effort To ‘End Blindness’ Marks Milestone With Leading Scientists Recognized For Pioneering Workhttps://modernod.com/news/effort-to-end-blindness-marks-milestone-with-leading-scientists-recognized-for-pioneering-work/2478623/End Blindness 2020, a joint effort by leading scientists and figures from the worlds of business, politics, culture, art, music and entertainment to rid the world of blindness, is about to mark a milestone. On December 14, 2020, 13 scientists will share
- Hydrus Microstent Receives Highest Designation of Any MIGS Device as Part of AAO Treatment Guidelineshttps://modernod.com/news/hydrus-microstent-receives-highest-designation-of-any-migs-device-as-part-of-aao-treatment-guidelines/2478570/Ivantis, developer of the novel Hydrus Microstent MIGS device, announced that the American Academy of Ophthalmology (AAO) has designated the Hydrus Microstent as “Level 1, Moderate Quality, Strong Recommendation.” The designation is the highest of any MIGS device in its 2020 Preferred Practice Pa
- Adaptilens Announces $1.6 Million in Seed Funding for Development of Accommodating IOLhttps://modernod.com/news/adaptilens-announces-1-6-million-in-seed-funding-for-development-of-accommodating-iol/2478536/Adaptilens announced a $1.6 million seed funding to fund the company’s development of an innovative accommodating IOL with the aim of allowing patients to live their lives free of glasses and contact lenses. The funding was led by Pillar VC with additional participat
- Leiters and EyeConnect International Announce Corporate Partnershiphttps://modernod.com/news/leiters-and-eyeconnect-international-announce-corporate-partnership/2478520/Leiters, a provider of ophthalmic compounded sterile preparations and pharmacy services, has entered into a partnership with EyeConnect International (ECI) in support of their newly created digital ophthalmic clinical networking platform. Terms of the deal were not disclosed. EyeCon
- Staar Surgical Begins Commercialization of EVO Viva Presbyopia Correcting Lenshttps://modernod.com/news/staar-surgical-begins-commercialization-of-evo-viva-presbyopia-correcting-lens/2478495/Staar Surgical announced the initial commercialization of its EVO Viva presbyopia correcting lens including the first patient implant. “The first patient received his EVO Viva lenses on October 23 in Belgium from Dr. Erik Mertens, and we are delighted to hear from Dr. Mertens that the pati
- Bausch Health and BHVI Announce Global Licensing Agreement For Myopia Control Contact Lenshttps://modernod.com/news/bausch-health-and-bhvi-announce-exclusive-global-licensing-agreement-for-myopia-control-contact-lens/2478422/Bausch Health has acquired an exclusive license for a myopia control contact lens design developed by BHVI, an Australian not-for-profit organization with an international focus on vision research. Terms of the deal were not disclosed. Bausch + Lomb will pair BHVI’s novel cont
- BVI Acquires Benz Research & Development, Strengthening IOL Design, Production and Sales Capabilitieshttps://modernod.com/news/bvi-acquires-benz-research-development-strengthening-iol-design-production-and-sales-capabilities/2478419/BVI announced its recent completion of the acquisition of Benz Research & Development and its customized contact lens subsidiary, SpecialEyes, both based in Sarasota, Florida. Terms of the deal were not disclosed. The Benz portfolio of performanc
- Johnson & Johnson Vision Presents New Myopia Progression and Contact Lens Findings at American Academy of Optometry Annual Meetinghttps://modernod.com/news/johnson-johnson-vision-presents-new-myopia-progression-and-contact-lens-findings-at-american-academy-of-optometry-annual-meeting/2478387/Johnson & Johnson Vision announced clinical data from the latest in myopia research at the American Academy of Optometry’s virtual annual meeting (Academy 2020). Investigators will also reveal findings that demonstrate how Acuvue Oasys 1-Day with Hydraluxe Technology Contact Lenses redu